Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health (Nasdaq: GH), a precision oncology company, announced its participation in three upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
William Blair 44th Annual Growth Stock Conference in
Chicago
Presentation on Tuesday, June 4 at 3:20 p.m. CT / 4:20 p.m. ET
-
Jefferies Global Healthcare Conference in
New York
Presentation on Wednesday, June 5 at 5:00 p.m. ET / 2:00 p.m. PT
-
Goldman Sachs 45th Annual Global Healthcare Conference in
Miami Beach, Florida
Fireside chat on Tuesday, June 11 at 2:00 p.m. ET / 11:00 a.m. PT
Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240522599294/en/
Investor Contact:
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.